Crestbridge Johnson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Private markets: Biotech funds point to the future Healthcare has had a year like no other for at least two reasons. The first is obvious. The second is all about investment.  In April, for example, healthcare ETFs saw their highest level of inflows – $7.3 billion at the global level. And although this amounted to just $0.5 billion in Europe, even that was a regional record. BlackRock, which published the numbers, said the interest in medical device production and in pharmaceutical innovation had offered investors two rationales for investing in the sector. At Goldman Sachs Asset Managemen...

Biotechnology – in the spotlight thanks to Covid-19 – surpasses even digital in terms of its scope to transform this century. Much of its funding comes from private equity, where investors face ethical as well as financial dilemmas. Alex Rolandi reports.